Nasopharyngeal cancer treatment with immunotherapy

In some cases, immunotherapy of nasopharyngeal cancer can be an effective way to help the patient's immune system find and kill cancer cells. But unfortunately, the tumor has mechanisms to hide from immunity. And the drugs return the neoplasm "visibility. " Thanks to their effects, nasopharyngeal cancer can no longer evade the immune system's attacks. As a result, the primary tumor and metastases decrease in size. In clinical practice, several types of drugs can be used to fight nasopharyngeal cancer, such as checkpoint inhibitors. These drugs do not directly affect the tumor but block signals that prevent the immune system from recognizing cancer. For example, Pembrolizumab and Nivolumab have proven themselves well for treating children and adults with recurrent nasopharyngeal cancer. First, the oncologist will conduct specific tests to determine whether the therapy will be effective in your case. Then, the doctor will prescribe the most appropriate medicine if the result is positive. Some medications are administered intravenously, others orally as pills or capsules. Some immunotherapies are given in cycles with breaks. For example, you can receive treatment every day, once a week, or once a month. The rest period lets your body recover, respond to immunotherapy, and create new healthy cells.